ArticleBulletin of experimental biology and medicine2025
Alimentary Disorders of Cholesterol and Fat Metabolism in Male Wistar Rats: an In Vivo Study.
Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safety and Efficacy Assessment of Cannabis Plant Compared to Atorvastatin for Lipid Lowering in Diabetic and Obese Wistar Male Rats.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We performed a comparative analysis of lipid and cholesterol metabolism disorders, as well as liver condition in male Wistar rats receiving high-fat diets with different cholesterol contents. Addition of 2% cholesterol to the diet resulted in a marked aggravation of fatty liver disease, characterized by extreme accumulation of fat and cholesterol. A diet supplemented with 0.5% cholesterol resulted in serum cholesterol accumulation and liver steatosis, but had no effect on weight gain or body composition. Introduction of 1% cholesterol to the diet induced similar abnormalities as 2% cholesterol, but without the extreme cholesterol and fat accumulation in the liver. This model can be used in the future to evaluate the effectiveness of the studied functional foods.
Indexed as
Identifiers
41186827What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.